Ergomed Provides Global Medical Affairs Guidance and Support 

Ergomed stands out with its unique suite of global medical affairs services, meticulously designed to cater to the intricate needs of complex trials. Our services include medical monitoring and study physician services, and our esteemed sister company, PrimeVigilance, provides pharmacovigilance services.

Driving Therapeutic Success

With a robust global presence, we deliver expert medical affairs services across diverse therapeutic areas, including oncology, rare diseases, and neurology. Our team’s commitment to scientific excellence and comprehensive services make us an ideal partner for clinical trial support services, driving successful therapeutic outcomes for sponsors and patients.

End-to-End Global Medical Affairs Services

  • We provide continuous medical monitoring and medical data review services through our expert team of medical monitors to ensure patient safety and data integrity throughout the clinical trial process.

Team Member Spotlight: 


Rachel Altura, MD, Executive Medical Director of Global Medical Affairs

Dr. Rachel Altura provides strategic, scientific, and operational leadership across Global Medical Affairs. With over 15 years of academic research and clinical experience in oncology and hematology, and more than a decade of industry experience, Dr. Altura specializes in the clinical development of large biologics, small molecules, and oncolytic viral therapies, with deep expertise in First-In-Human (FIH) studies and Phase I–III trial design across adult and pediatric solid tumors and hematologic malignancies.

Dr. Altura is board certified by the American Board of Pediatrics, with a sub-board certification in Pediatric Hematology-Oncology and holds a medical degree from Washington University School of Medicine. She has held academic appointments at the Assistant and Associate Professor levels at The Ohio State University and The Warren Alpert Medical School at Brown University. She has authored many peer-reviewed publications in high-impact journals including The Journal of Clinical Oncology, Clinical Cancer Research, and Nature Communications, and has presented her research at leading conferences including ASCO, ASCO GI, AACR, and ESMO. She is a longstanding member of the American Society of Hematology (ASH) and the American Society of Clinical Oncology (ASCO) and has served on the medical review board for several scientific and medical journals and conferences.

Throughout her career, Dr. Altura has combined rigorous scientific leadership with a deep commitment to patient safety, mentoring the next generation of medical professionals and building lasting relationships with Key Opinion Leaders and Principal Investigators worldwide.

Patient-Centric Approach

Ergomed’s global medical affairs team is not only dedicated but also passionate about working collaboratively and effectively to ensure the success of every clinical trial. Our patient-centric approach is not a mere strategy but a core value that drives us to understand and address the unique needs of each trial and participant. This ensures that we deliver not just solutions, but tailored solutions that meet the highest standards of quality, safety, and compliance.

Innovative Monitoring Strategies

We enhance early issue detection, cost reduction, and data quality improvement by integrating our expertise and innovative risk-based monitoring strategies. Our strategies include statistical, centralized, reduced, triggered, and remote monitoring, each tailored to the specific needs of each trial site. These approaches allow us to proactively manage potential risks and ensure the smooth progression of clinical trials.

Commitment to Excellence

Our unwavering commitment to scientific excellence drives us to provide our clients with the highest level of service. We strive to deliver accurate, reliable, and timely data that support the development of new therapies and enhances patient therapeutic outcomes. Our dedication to quality and compliance ensures that all trials follow the highest industry standards.

Collaboration and Support

Collaboration is vital to the success of any clinical trial. Our team works closely with sponsors, investigators, and other stakeholders to provide comprehensive support throughout the trial process. We ensure clear communication and effective problem-solving, fostering a collaborative environment that drives the success of each project.

Discover How Ergomed Can Support Your Clinical Trial

At Ergomed, we are dedicated to delivering outstanding global medical affairs services that ensure the success of your clinical research. As your partner in clinical research, we strive to provide the highest quality of service, setting us apart from other CROs.

Reach out to us today to discover how we can support your clinical trials and help you efficiently and effectively bring your innovative therapies to patients.

Dedicated Partnership, Ergo, Successful Outcomes

Contact Us

Our Complementary Services

See how Ergomed can support your clinical trial.

More Ergomed Services

Find out how Ergomed supports your clinical trial objectives.

Discover Our Latest Insights

Access Ergomed's resources for the latest in clinical trial trends and innovations.